Skip to content
★ Sign in to follow
TM
Total declarations
4
Company
1
▲ Purchases (4 ops.)
€177k
▼ Sales (0 ops.)
—

Latest filing published 20 Nov 2024 for AstraZeneca PLC, €2,275.

Filing timeline

BuySale
Tony Mok

Insider track record

Disclosed buys
4
Disclosed sells
0
Signal history

Closed purchases

Market purchases
4

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Tony Mok: trading record in brief

Tony Mok is a declared insider of AstraZeneca PLC, with filings sourced from Finansinspektionen. The record holds 4 filings, for trades running from 26 February 2020 to 19 November 2024.

No open-market sale appears; the market trades are 4 purchases worth €177k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2024: 1 purchase and no sales on the market.

A typical purchase (the median) is worth €39k. 3 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.

The newest entry dates from 20 November 2024: an open-market purchase of €2,275, in AstraZeneca PLC. The median gap between a trade and its publication by Finansinspektionen is 2 days. The legal deadline for notifying a trade is three business days (MAR article 19). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Tony Mok

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ▲
    Non-Executive DirectorExecutivesAstraZeneca PLC
    1,902 GBP27RNS
    3,000 shares@ £0.634100.0% of flowXNASRNS:5437579
    Canonical exit: 17 Feb 2025 (T+90)
  • ▲
    Non-Executive DirectorExecutivesAstraZeneca PLC
    108,580 USD10FCA-NSM
    2,000 shares@ US$54.2926.1% of flowXNASFCA-NSM:4213070
    Canonical exit: 13 Mar 2022 (T+90)
  • ▲
    Non-Executive DirectorExecutivesAstraZeneca PLC
    38,320 USD23FCA-NSM
    1,000 shares@ US$38.3242.9% of flowNYSEFCA-NSM:LSE20200320070006_3534123_20200402152614269
    Canonical exit: 16 Jun 2020 (T+90)
  • ▲
    Non-Executive DirectorExecutivesAstraZeneca PLC
    48,000 USD24FCA-NSM
    1,000 shares@ US$48.0054.3% of flowNYSEFCA-NSM:LSE20200227070012_3507755_20200331164945395_26107
    Canonical exit: 26 May 2020 (T+90)

4 of 4 declarations